Viral Vector Vaccines Suppliers & Bulk Manufacturers
Available Forms: Intramuscular injectable suspension (IM)
Available Strengths: 0.5 mL
Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)
Category:
Vaccines
Viral vector vaccines use a harmless virus to deliver genetic material encoding the target pathogen’s antigen, stimulating immunity. They elicit robust cellular and antibody responses, offering effective protection against diseases like COVID-19. Benefits include rapid development, strong immune response, and long-lasting protection, supporting global disease control efforts.
Viral Vector Vaccines is available in Intramuscular injectable suspension (IM)
and strengths such as 0.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Viral Vector Vaccines is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Viral Vector Vaccines can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Viral vector vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval involves extensive clinical trials, while in the EU, CE marking certifies conformity with in vitro diagnostic and medicinal regulations. These vaccines undergo validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective viral vector vaccines vital for disease prevention, outbreak control, and global health initiatives.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing